Register entry
Corcept Therapeutics Incorporated
- Registered sites
- 0
- Drug products
- 6
- Live patents
- 28
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
28Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| KORLYM | MIFEPRISTONE | Aug 2028 |
| KORLYM | MIFEPRISTONE | Nov 2032 |
| KORLYM | MIFEPRISTONE | Mar 2033 |
| KORLYM | MIFEPRISTONE | Apr 2036 |
| KORLYM | MIFEPRISTONE | Aug 2036 |
| KORLYM | MIFEPRISTONE | Aug 2036 |
| KORLYM | MIFEPRISTONE | Jan 2037 |
| KORLYM | MIFEPRISTONE | Jun 2037 |
| KORLYM | MIFEPRISTONE | Aug 2038 |
| LIFYORLI (COPACKAGED) | RELACORILANT | May 2033 |
| LIFYORLI (COPACKAGED) | RELACORILANT | Dec 2039 |
| LIFYORLI (COPACKAGED) | RELACORILANT | Apr 2040 |
| LIFYORLI (COPACKAGED) | RELACORILANT | May 2041 |
| LIFYORLI (COPACKAGED) | RELACORILANT | Dec 2041 |
Catalogue
Marketed products
6Showing 6 of 6.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Korlym | Mifepristone | TABLET | NDA |
| Lifyorli | Relacorilant | KIT | NDA |
| Lifyorli | Relacorilant | KIT | NDA |
| Lifyorli | Relacorilant | KIT | NDA |
| Lifyorli | Relacorilant | KIT | NDA |
| Mifepristone | Mifepristone | TABLET | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.